100% tevredenheidsgarantie Direct beschikbaar na betaling Zowel online als in PDF Je zit nergens aan vast
logo-home
Summary of lectures about drug delivery and development €3,49   In winkelwagen

Samenvatting

Summary of lectures about drug delivery and development

 4 keer bekeken  0 keer verkocht

summary including pictures

Voorbeeld 2 van de 14  pagina's

  • 29 oktober 2023
  • 14
  • 2023/2024
  • Samenvatting
Alle documenten voor dit vak (11)
avatar-seller
daniquelichtenberg
Week 2 Drug delivery & development
SMDs/biologics

LE Drug Targeting and Delivery (Part I) (Rik Oude Egberink)
Classical drugs (like paracetamol) are small organic molecules that are usually lipophilic enough to
cross membranes (distribute well throughout body). They act by inhibiting enzymes/receptors. If you
want to use (m)RNA as drugs (they are not drugs by themselves), they need a transport vehicle or
you make a nanoparticle of the RNA.

SiRNA is negatively charged and large thus it cannot get into the cell, but if it can enter the cell via a
transport way it can act as a drug.

Risk of side effects by

- Insufficient specificity (cross reactivity with other targets) because it can distribute well
thoughout the body
- Inhibition of important metabolic routes in non-target organs

Classical drugs are poor inhibitors of protein-protein interactions due to large surface area and weak
binding of the proteins. Classical drugs need deep pockets for binding. So bigger proteins are needed
(like antibodies). Oligonucleotides (such as mRNA)offer a very straightforward way to inhibit/change
protein expression.

Drug targeting goal is to enhance concentration of a drug at site-of-action (avoid side effects,
minimize costs, minimize dose, and increase t1/2).

Drug targeting = how do we accumulate drugs at a target site

Drug delivery = how do we get the drug at the site

- Minimal design
- No toxicity
- Elimination of vehicle (secretion vs break-down)
- Compatibility with drug to be targeted (hydrophobic or hydrophilic)
- Costs
- Stability (therapeutics and storage)

We want the drug to remain undetected from the immune system, but you want it to specifically find
and hit the target.

Nanomedicine consists of a matrix containing the drug (both matrix and drug should be hydrophobic
OR hydrophilic), with a surface modification and a receptor for targeting ligand = all biodegradable




Esther: C with double bonded O, is what you degrade by hydrolysis (biodegradable by metabolism)

, PLGA breaks down in minutes but is adjustable so it breaks down over years (used for prestethic and
slow releasing medicine (like insulin)

Delivery routes

- Peroral = oral
- Pulmonal = lungs
- Ophthalmic = eyes
- Percutane = through skin (don’t need doctor)
- Intravenous = into bloodstream
- Intrathecal = injection in spine (passing blood-brain barrier)

Delivery route dictated which barriers the drugs will encounter. There are 3 barriers: epithelial,
endothelial and plasma membrane. Number and nature of barriers are organ-dependent = important
for exam




There are 3 types of capillary endothelia:

- Continuous: endothelial layer with intercellular clefts. Skeletal muscle contains many
transport vesicles, and BBB contains few vesicles.
- Fenestrated: endothelial layer with fenestrations (60-80 nm). Small proteins can pass.
Present in endocrine glands, intestines, pancreas, and glomeruli.
- Sinusoid: endothelial layer with intercellular gaps (30-40 microns) and an incomplete
basement membrane. Entire cells can pass. Present in the bone marrow, lymph nodes, liver,
and spleen.

A cell is 10-20 microns




- Transcellular transport = transport via endocytosed and exocytosis. Cargo should be
recognized. You can conjugation a drug to a metabolic cargo (e.g. vitamin can be conjugated
to insulin) = conjugation strategy (also used in BBB).
- Paracellular transport = transport between cells. Tight junction proteins can tighten or loosen
via calcium signaling, to let proteins diffuse. Too small for nanomedicines. Small proteins
max.
- Nanomedicine: for non-destructive transport, there is no permeation enhancement without
activation of intracellular processes.

Voordelen van het kopen van samenvattingen bij Stuvia op een rij:

Verzekerd van kwaliteit door reviews

Verzekerd van kwaliteit door reviews

Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!

Snel en makkelijk kopen

Snel en makkelijk kopen

Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.

Focus op de essentie

Focus op de essentie

Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!

Veelgestelde vragen

Wat krijg ik als ik dit document koop?

Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.

Tevredenheidsgarantie: hoe werkt dat?

Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.

Van wie koop ik deze samenvatting?

Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper daniquelichtenberg. Stuvia faciliteert de betaling aan de verkoper.

Zit ik meteen vast aan een abonnement?

Nee, je koopt alleen deze samenvatting voor €3,49. Je zit daarna nergens aan vast.

Is Stuvia te vertrouwen?

4,6 sterren op Google & Trustpilot (+1000 reviews)

Afgelopen 30 dagen zijn er 57114 samenvattingen verkocht

Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen

Start met verkopen
€3,49
  • (0)
  Kopen